Saturday, June 10, 2023 11:53:04 AM
On another front it looks like the company has entered into a phase of steady press releases again on the OTC boards. This is a positive sign of increased communication with shareholders documenting company activities as well. One caveat is the press releases on the OTCMarkets news board are absent from the company website. Seems like a simply task to keep both up to date. Anyone want to volunteer to port them for them. Lol
One last item. As investors it seems like spurring a northern migration on the price point in response to the company reporting profit is a good idea. Seems like it's time for a higher needle point. Let's get this baby moving.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM